The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EGFR gene copy number to predict response to anti-EGFR treatment and survival in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer.
 
Olli Carpen
Stock and Other Ownership Interests - Orion
Patents, Royalties, Other Intellectual Property - Turu University Hospital (Inst)
 
Annika Ålgars
Patents, Royalties, Other Intellectual Property - Turku University Hospital (Inst)
 
Jari Sundström
Patents, Royalties, Other Intellectual Property - Turku niversity Hospital (Inst)
 
Soili Kytölä
No Relationships to Disclose
 
Pia Österlund
Honoraria - Amgen; Baxalta; Bayer; Celgene; Lilly; Merck; Nordic Drugs; Prime Oncology; Roche/Genentech; Sanofi
Consulting or Advisory Role - Amgen; Baxalta; Bayer; Celgene; Lilly; Merck; Nordic Drugs; Roche; Sanofi
Research Funding - Amgen; Merck; Roche; Sanofi
 
Minnamaija Lintunen
Patents, Royalties, Other Intellectual Property - Turku University Hospital (Inst)
 
Terhi Jokilehto
No Relationships to Disclose
 
Milja Kaare
No Relationships to Disclose
 
Arto Orpana
No Relationships to Disclose
 
Reetta Vainionpää
No Relationships to Disclose
 
Ari Ristimäki
No Relationships to Disclose
 
Raija Ristamäki
Patents, Royalties, Other Intellectual Property - Turku University ospital (Inst)